Clinical Trial Update: Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the oral CF101 in combination with methotrexate for rheumatoid arthritis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CF101 (piclidenoson)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Can-Fite BioPharma | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2015-03-17